Health Insurance (Application for Acceptance of Approved Pathology Authority Undertaking) Determination 2018

The instrument is narrowly focused and administrative. Its primary legal concept is a prescription of mandatory application particulars for obtaining acceptance of an approved pathology authority undertaking under the Health Insurance Act 1973. The key statutory hooks and defined-concept relationships in the instrument are:

• Statutory authority: the determination is made under subsection 23DF(13) of the Health Insurance Act 1973 (s 3). Section 5 explicitly ties the instrument’s requirements to paragraph 23DF(2)(c) and subsection 23DF(1) of the Act by providing that an application under the Act must contain the particulars in Schedule 1 (s 5).
• Definitions and cross-references: the instrument defines ACN by reference to section 9 of the Corporations Act 2001 and defines Act to mean the Health Insurance Act 1973 (s 4). The instrument also notes that several expressions used are defined in s 3(1) of the Act, including ABN, approved pathology authority and proprietor (s 4, note). These cross-references integrate corporate and tax identity markers (ACN, ABN) with the administrative architecture of the Health Insurance Act.
• Particulars as a statutory precondition: Schedule 1 enumerates the particulars required for applications. The list is structured by the applicant/proprietor legal form and includes contact information for an authorised representative (Schedule 1, items 1-9). Item 10 is a structured fit-and-proper-person disclosure requirement that cross-references multiple provisions of the Act (subsections and sections cited in Schedule 1, item 10).
• Repeal and consolidation: Schedule 2 expressly repeals the 2002 Determination in full (Schedule 2, item 1), so the 2018 instrument replaces the earlier instrument’s role in specifying application particulars or form.

Conceptually, the instrument functions as a technical rule on information supply in an administrative authorisation process. It translates the statutory power in s 23DF of the Act (not reproduced in the instrument) into a checklist of particulars the department will require for processing an application. The fit-and-proper enquiries are implemented by requiring applicants to disclose relationships with persons who have been subject to notices, determinations or convictions under various provisions of the Act (Schedule 1, item 10). The instrument is therefore a point of integration between documentary identity (ABN/ACN, company directors, shareholders) and regulatory suitability (fit-and-proper disclosures referencing Act provisions).

The instrument affects applicants under subsection 23DF(1) of the Health Insurance Act 1973 seeking acceptance of an approved pathology authority undertaking and anyone who is a proprietor, partner, director, principal officer, or otherwise associated with the applicant to the extent their information is required by Schedule 1.

More specifically, the affected parties are:

• Approved pathology authorities or entities applying for a new approved pathology authority undertaking or to renew/update the details of an existing undertaking. The application type must be declared (Schedule 1, item 1).
• Proprietors of the undertaking, defined to include individuals, partnerships, companies, or government agencies/public bodies. The instrument requires different particulars depending on which category applies: individual name (item 5), partnership partners’ names and shares plus ABN/ACN (item 6), company ACN, registered business name, directors’ names, principal shareholders and approximate percentage holdings (item 7), or government agency details (item 8).
• Authorised representatives designated by the applicant. The instrument requires an authorised representative’s name and multiple contact points, including daytime phone, mobile, fax and email (Schedule 1, item 3).
• Principal officers of the proprietor: names and positions of principal officers must be supplied (Schedule 1, item 9).
• Persons with financial, employee/employer or business relationships with the applicant who may be subject to prior notices, determinations or convictions under specific provisions of the Health Insurance Act. Schedule 1, item 10 requires disclosure of relationships with persons who have been given notices under s 23DL(1) or to chairpersons under ss 23DL(4) or 124D, notices under ss 124FA(3) or 124FE(3), determinations by a Medicare Participation Review Committee under ss 124F, 124FB, 124FC or 124FF, notices under s 102, final determinations under s 106TA, or persons convicted of relevant offences as defined in s 23DA. Where an applicant discloses such a relationship, the name, company name and provider number of the person must be provided (Schedule 1, item 10(2)).
• Entities that relied on the 2002 Determination for their application processes. That instrument is repealed in full by Schedule 2 (Schedule 2, item 1), so such entities must adjust to the new particulars prescribed.

Who pays and who acts: the applicant (or the proprietor acting through an authorised representative) bears the information-gathering and disclosure burden because the instrument prescribes what must be included in the application (s 5; Schedule 1). The Department of Health, represented by the delegate who made the instrument (David Weiss, First Assistant Secretary, Medical Benefits Division), is the administrative decision-making and processing body by implication from the instrument’s origin and the statutory scheme (instrument header; s 3). The instrument does not specify fees, but it operationally compels applicants to assemble and submit defined particulars.

Duties prescribed by the instrument

• Duty to provide specified particulars in applications: Section 5 makes it mandatory that an application under subsection 23DF(1) of the Health Insurance Act 1973 contains the particulars specified in Schedule 1. That is the core legal duty imposed by the instrument (s 5).
• Duty to disclose identity and contact details: Schedule 1 requires the applicant to provide the approved pathology authority number for renewals (item 2(1)), the approved pathology authority name (item 2(2)), registered address and address for correspondence (items 2(3)-(4)), and an authorised representative’s full contact suite (Schedule 1, item 3).
• Duty to declare proprietor legal form and supply corporate and tax identifiers: Schedule 1 item 4 requires disclosure of the proprietor’s ABN and ACN, registered trading name ownership and the trading name registration expiry date, and whether the proprietor is an individual, partnership, company or government agency/public body (item 4).
• Duty to provide tailored proprietor particulars: depending on the proprietor’s legal form, the applicant must provide details specified in items 5-8 (full name for individuals; partners’ names, percentage shares, ABN and ACN for partnerships; company directors, principal shareholders and approximate share percentages for companies; registered business name and ACN for government agencies/public bodies).
• Duty to provide principal officers’ names and positions (Schedule 1, item 9).
• Duty to make “fit and proper” disclosures: Schedule 1, item 10 requires the applicant to disclose whether the applicant, or any person with whom the applicant has (or proposes to have) a relevant relationship, has been the subject of certain notices, determinations or convictions referenced in various sections of the Act. If such a relationship exists, the applicant must provide identifying information for that person (item 10(2)).
• Duty to supply any additional supporting information at the applicant’s discretion or as required (Schedule 1, item 11).

Rights implicit or reserved by the instrument

• Right to apply for acceptance under s 23DF(1) of the Act remains intact; the determination prescribes particulars required to exercise that right but does not purport to create or extinguish the substantive right to apply (s 5).
• Right to submit further supporting information: Schedule 1, item 11 expressly contemplates additional information to support the application.
• Right to rely on statutory definitions and cross-reference: the instrument relies on definitions in the Act (s 4 note) and on the Corporations Act for ACN (s 4). Applicants can refer to those statutes for interpretative assistance.

What the instrument does not do

• It does not itself create offences, penalties or procedural decision rules for acceptance or refusal; it prescribes the content of applications only (s 5). Enforcement and consequences for non-compliance are a function of the Health Insurance Act and administrative practice not contained in the instrument.
• It does not prescribe the format of the form in the text beyond listing particulars. The instrument’s title suggests acceptance of an “approved pathology authority undertaking” form, but the operative text (s 5 and Schedule 1) lists particulars rather than embedding a form text.

Practical implication of the duties

• The duties are documentary and disclosure-based. Compliance requires assembling corporate identity documents (ABN, ACN), corporate governance information (directors, shareholders and share percentages), partnership schedules (share percentages and tax/corporate identifiers), authorised-representative contact details and a historical compliance screening for persons connected to the applicant under the Act’s specified sections (Schedule 1, item 10). The combination of these duties converts the statutory application into an evidence and information-gathering exercise.

The instrument itself does not create criminal or civil penalties and does not set out enforcement procedures. Its function is to prescribe what an applicant must include in an application under subsection 23DF(1) of the Health Insurance Act 1973 (s 5). Enforcement of compliance with the particulars, and any consequences for false or incomplete information, falls to the Health Insurance Act and the administrative powers conferred by it, not to this determination itself (s 3; s 5).

What the instrument says about enforcement and consequences

• There are no express penalty clauses, sanctions, or administrative enforcement mechanisms in this instrument. The legal effect is limited to mandatory content: an application "must contain the particulars as specified in Schedule 1" (s 5). The instrument prescribes content requirements; it does not state the consequences for failing to comply with those requirements.
• Fit-and-proper disclosures (Schedule 1, item 10) direct applicants to declare connections with persons who have been given notices or subject to determinations or convictions under specified provisions of the Health Insurance Act. The instrument requires disclosure but does not itself adjudicate suitability or provide the consequences for adverse disclosures. Those consequences would be derived from the provisions of the Act referred to in the Schedule and administrative decisions taken under the Act.

Practical enforcement implications to note (as drawn from the instrument’s architecture)

• Administrative discretion under the Act: enforcement in practice will depend on how the Department of Health and decision-makers under the Health Insurance Act apply their powers when processing an application containing these particulars. The instrument vests operational authority in the statutory framework (s 3); it does not specify departmental decision rules or internal processing steps.
• Evidence and accuracy exposure: because the instrument requires specific corporate and personal details (directors, principal shareholders, share percentages, ABN/ACN, provider numbers where relevant), inaccurate or incomplete particulars may impede processing. The instrument does not say whether an application containing incorrect particulars will be treated as invalid, returned, or otherwise handled; those consequences are for the Act and administrative procedure.
• Reliance on external statutory determinations and notices: item 10 requires disclosure of persons who have been subject to a range of notices and determinations under the Act. If such disclosures are made, subsequent administrative action (including possible refusal or restrictions) would follow from the Act’s provisions and decision-making under it, not from the instrument itself.

In short, the determination prescribes document and disclosure duties; it delegates enforcement and consequence-setting to the Health Insurance Act framework and to the administrative authorities responsible for processing the applications. Readers should consult the Health Insurance Act provisions cited in the instrument for the substantive enforcement regime that will apply to the facts disclosed under these particulars.

The instrument expressly cross-references and relies upon other statutes and specific provisions of the Health Insurance Act. Its effectiveness and interpretation are interdependent with those instruments and statutory terms.

Cross-references inside the instrument

• Corporations Act: The instrument defines ACN by referring to section 9 of the Corporations Act 2001 (s 4). That means the meaning of ACN used in Schedule 1 aligns with the corporate identification regime under the Corporations Act.
• Health Insurance Act 1973: The instrument sits as a subordinate instrument under subsection 23DF(13) of the Act (s 3). The definitions note that several expressions used are defined in section 3(1) of the Act, including ABN, approved pathology authority and proprietor (s 4 note). Most materially, s 5 ties the prescribed particulars directly to paragraph 23DF(2)(c) and subsection 23DF(1) of the Act, so the legal effect of failing to supply the particulars, or the consequences of information disclosed under Schedule 1, will be governed by the statutory scheme under the Act.
• Internal cross-references to substantive Act provisions for fit-and-proper assessment: Schedule 1, item 10 requires disclosure where the applicant, or associated persons, have been subject to notices or determinations under particular sections of the Health Insurance Act: subsection 23DL(1), subsections 23DL(4) or 124D, subsections 124FA(3) or 124FE(3), determinations under sections 124F, 124FB, 124FC or 124FF, notices under section 102, final determinations under section 106TA, and convictions for relevant offences as defined in section 23DA of the Act. These cross-references create a dependency: to complete the application accurately, applicants must understand the meaning and practical effects of those sections.
• ABN: although ABN is not defined inside this instrument, the instrument’s note points applicants to the Act’s definitions (s 4 note). ABN is generally a tax/identity number relevant under the Taxation and Corporations regimes; the instrument assumes those external identification systems supply the authoritative identifiers.

Operational interactions and practical dependencies

• Information verification: listing ACN and ABN, company directors, shareholders and share percentages creates a point of interaction with corporate registers (eg, the Australian Securities and Investments Commission for ACN-based information) and the Australian Business Register for ABN. The instrument does not itself require third-party verification, but the particulars it asks for are identical to the data fields held in those external systems.
• Dependence on Medicare/administrative determinations: item 10 refers to notices given to chairpersons of Medicare Participation Review Committees and determinations made by such committees (Schedule 1, item 10). The presence or absence of such notices/determinations will affect the disclosure obligations. Completing the fit-and-proper disclosure likely requires searching or otherwise checking administrative records under the Health Insurance Act and Medicare-related registers.
• Repeal interaction: Schedule 2 repeals the 2002 Determination, so the 2018 Determination now occupies the space of subordinate legislation that prescribes particulars for application. Stakeholders must ensure they apply the 2018 terms rather than any prior instrument (Schedule 2, item 1).

What the instrument does not do in relation to other laws

• The instrument does not amend the Corporations Act or the Health Insurance Act; it relies on them for definitions and for the substantive regime to which these particulars relate (s 4; s 3). It also does not set out any privacy or information-sharing rules, although the particulars requested will include personal and corporate identifiers that are otherwise subject to privacy and public-register regimes. How those data are held, used or disclosed for regulatory purposes will be governed by applicable privacy and administrative law frameworks, not by this instrument.

In sum, the instrument is an administrative connector: it imports identifiers and governance data that sit principally in corporate and tax law registers, and it predicates fit-and-proper disclosure obligations on determinations, notices and convictions under specified provisions of the Health Insurance Act. Applicants and advisers must therefore work across the Act, the Corporations Act identifiers, and administrative records when preparing an application.

This instrument contains only the original provisions as made in 2018 and a repeal of the earlier instrument. The instrument’s own amendment history within its text is minimal and focused on substitution of the 2002 Determination.

Key points in the instrument about amendments and commencement

• Commencement: The instrument commences the whole instrument the day after it is registered (s 2(1), Commencement table). The table includes an editorial note that the table relates only to the provisions as originally made and will not be amended to deal with later amendments (s 2 note).
• Repeal of prior instrument: Schedule 2, item 1 repeals the Health Insurance (Application For Acceptance Of Approved Pathology Authority Undertaking) Determination 2002 in its entirety. That repeal is the only express repeal or amendment recorded in the instrument.

What is not in the instrument’s amendment history

• The instrument does not record previous amendments to itself because it is a fresh instrument made in 2018 replacing the 2002 instrument. There are no later amending items or modification clauses inside the instrument text supplied.
• The instrument includes an administrative clause (s 6) stating that each instrument specified in Schedule 2 is amended or repealed as set out in the applicable items in that Schedule, and that any other item in a Schedule has effect according to its terms. In this instrument, Schedule 2 contains only one item which effects the full repeal of the 2002 Determination (s 6; Schedule 2, item 1).

Practical implications of the amendment/repeal

• Transition: because the previous 2002 Determination is repealed in full, any forms, procedures, or expectations derived from the 2002 Determination cease to have legislative force as of the 2018 instrument’s commencement. The instrument itself does not include transitional provisions; practitioners should look to administrative practice or departmental guidance for any transitional arrangements. The instrument’s text provides no such transitional statements.
• Publication metadata: s 2(2) includes an editorial provision that information in column 3 of the commencement table is not part of the instrument and may be edited in published versions. That is a drafting/administrative note rather than a substantive amendment history element, but it is relevant for version control and how published copies may present non-legislative information.
• Future amendments: the instrument does not itself include a sunset, review clause, or explicit amendment pathway. As a statutory instrument made under the Health Insurance Act, future amendments would be made by subsequent determinations under the same enabling provision or by legislative amendment to the Act that alters the enabling power.

The text supplied contains no litigation history, judicial references, or cases arising from this instrument. The instrument does not cite any decisions nor does it refer to judicial interpretation of its terms. It is a subordinate administrative instrument that prescribes application particulars, and no cases are mentioned in the instrument text itself.

What the instrument does show that might generate litigation issues (but without naming cases)

• The instrument places a clear information duty on applicants to disclose fit-and-proper relationships under item 10 of Schedule 1. Disagreements about what constitutes a relevant relationship, interpretation of the notices and determinations referred to, or the adequacy of the particulars provided could be the subject of administrative review or litigation under the Act. However, the instrument does not itself provide or cite any litigation outcomes.
• Because the instrument repeals the 2002 Determination in whole (Schedule 2, item 1), any disputes arising from applications submitted under the previous instrument before the repeal date would fall for resolution under the Act and may involve questions of transitional treatment. The instrument does not specify transitional arrangements, so potential litigation or review might depend on administrative practice and the timing of applications around the repeal; again, the instrument contains no litigation references.

If a reader requires judicial interpretation or case law applying these requirements, those materials are not contained in the instrument and should be sought separately (for example, any administrative law judgments interpreting how the Health Insurance Act’s application requirements operate in practice). The instrument itself contains no litigation citations.

This instrument is short but contains a number of details and drafting features that can cause operational and compliance pitfalls. The following are concrete points to watch, grounded in the instrument text.

1. Strict list of particulars: Section 5 makes the inclusion of the Schedule 1 particulars mandatory for applications under subsection 23DF(1) of the Act. An application that omits any required particular may be treated as incomplete under the administrative regime that applies to s 23DF applications. The instrument itself does not specify the consequence of omission, but practitioners should not assume partial disclosure suffices because the statutory wording in s 5 is mandatory.

2. Multiple identity numbers required: The instrument requires ABN and ACN for the proprietor where applicable (Schedule 1, item 4(1)-(2)). Practitioners must ensure they provide the correct identifiers and match them to the proprietor legal form. Failure to match registered names and identifiers could delay processing.

3. Proprietor legal-form specific requirements: Different particulars are required depending on whether the proprietor is an individual, partnership, company or government agency/public body (Schedule 1, items 5-8). For companies, the instrument requires names of all directors and names and approximate percentage holdings of principal shareholders (Schedule 1, item 7). For partnerships, it requires each partner’s percentage share plus ABN/ACN (Schedule 1, item 6). These are exacting information requirements, and the form requires approximate percentages for shareholders, which can be sensitive or difficult to present where shareholding is complex.

4. Trading name ownership and expiry date: The instrument asks for a registered trading name and the date that trading name registration expires (Schedule 1, item 4(3)-(4)). Applicants must confirm trading name ownership and record of expiry dates; an oversight here can be an overlooked compliance gap.

5. Contact detail expectations include fax: The authorised representative particulars include a fax number (Schedule 1, item 3(4)). Although many organisations no longer use fax, the instrument still lists it as a required field; practitioners should not omit it and should supply either an active fax number or the relevant alternative if permitted by the department in practice.

6. Fit-and-proper disclosure complexity: Schedule 1, item 10 requires disclosure of relationships with persons to whom a range of notices or determinations under the Act have been given or made, and convictions of relevant offences under s 23DA. Understanding whether a person falls within the referenced categories requires familiarity with the Act’s notice and determination regimes (the instrument references ss 23DL(1), 23DL(4), 124D, 124FA(3), 124FE(3), sections 124F, 124FB, 124FC, 124FF, s 102, s 106TA and s 23DA). Applicants must check administrative records and may need to obtain provider numbers and company names for any disclosed persons (Schedule 1, item 10(2)).

7. Broad relationship definition for fit-and-proper: The fit-and-proper disclosure extends to persons with whom the applicant has, or proposes to have, a financial, employee/employer or business relationship (Schedule 1, item 10). This broad phrasing requires forward-looking assessment,the applicant must disclose proposed relationships that meet the description.

8. Repeal of 2002 Determination without transition text: Schedule 2 repeals the 2002 Determination in full (Schedule 2, item 1). The instrument contains no transitional provisions. Entities operating under assumptions or forms derived from the 2002 Determination should not assume continuity of process and should update documentation and practice to match the 2018 particulars.

9. “Information in column 3” is not part of the instrument: s 2(2) expressly states that any information in column 3 of the commencement table is not part of the instrument and may be inserted or edited in published versions. Practitioners must therefore rely on the instrument text itself rather than ancillary publication notes when identifying legal obligations.

10. No explicit form text or signature block: The instrument prescribes particulars but does not attach an application form template or specify signature/attestation requirements in the text supplied. In practice, the department may supply a form, but the instrument itself is silent about attestation, evidence to support particulars, or signature requirements. Applicants should check the department’s application procedures to determine how these particulars must be presented, authenticated and supported.

11. Data privacy and handling not specified: The instrument requires personal and corporate data but does not set out how the department will handle, store or disclose that data. Applicants should be mindful that they are supplying potentially sensitive information and may need to consult departmental guidance or privacy laws for how that information will be managed.

These are concrete operational issues that arise from the text. Because the instrument focuses on the information required, the principal compliance risk lies in mis-assembly, omission, or inaccurate disclosure of the particulars listed.

The instrument prescribes a documentary checklist. Compliance is therefore primarily an exercise in assembling, verifying and disclosing the particulars listed in Schedule 1 and ensuring the application is lodged in accordance with the administrative requirements of the Health Insurance Act regime. The following is a practical, source-grounded compliance checklist and suggested steps an applicant or adviser should take, rooted in the instrument’s specific fields.

Step 1 , Confirm the application type (Schedule 1, item 1)

• Declare expressly whether the application is for a new approved pathology authority undertaking or to renew/update details of an existing undertaking (item 1(1)(a)-(b)).
• For renewals/amendments, obtain the existing approved pathology authority number (item 2(1)).

Step 2 , Compile applicant identity and contact details (Schedule 1, item 2)

• Provide the approved pathology authority name (item 2(2)).
• Provide the registered address (item 2(3)) and address for correspondence (item 2(4)).
• Ensure address details match corporate records to avoid processing delays.

Step 3 , Appoint and document an authorised representative (Schedule 1, item 3)

• Record the authorised representative’s full name (item 3(1)).
• Provide daytime phone, mobile, fax and email (items 3(2)-(5)). If a fax is not used, confirm with the department whether an alternative should be provided; do not leave the field blank.

Step 4 , Establish proprietor legal form and identifiers (Schedule 1, item 4 and s 4)

• Determine proprietor type (individual, partnership, company, government agency/public body) and state it (item 4(5)(a)-(d)).
• Supply ABN and ACN where requested (item 4(1)-(2)). The instrument defines ACN with reference to Corporations Act s 9 (s 4), so use the official ACN from ASIC records.
• Provide any registered trading name and the date the trading name registration expires (item 4(3)-(4)). Confirm the trading name is owned by the applicant as required.

Step 5 , Provide proprietor-specific particulars (Schedule 1, items 5-8)

• If an individual proprietor, give the full name (item 5(1)).
• If a partnership, list each partner, each partner’s percentage share, ABN and ACN (item 6(1)(a)-(d)).
• If a company, provide registered business name, ACN, names of all directors, names and approximate percentage shareholding of principal shareholders in order of shareholding (item 7(1)(a)-(e)). Ensure consistency with company registers.
• If a government agency/public body, provide registered business name and ACN (item 8(1)(a)-(b)).

Step 6 , List principal officers (Schedule 1, item 9)

• Provide names and positions of principal officers of the proprietor (item 9(1)). Confirm internal governance records to ensure accuracy.

Step 7 , Conduct fit-and-proper screening and disclose results (Schedule 1, item 10)

• Investigate whether the applicant, or any person with whom the applicant has or proposes to have a financial, employee/employer or business relationship, has been the subject of notices, determinations or convictions as set out in item 10(1). The relevant references are subsection 23DL(1), subsections 23DL(4) or 124D, subsections 124FA(3) or 124FE(3), determinations under sections 124F, 124FB, 124FC or 124FF, notices under section 102, final determinations under section 106TA, and convictions for relevant offences as defined in section 23DA of the Act (Schedule 1, item 10(1)).
• If any such relationships exist, disclose the name, company name and provider number for each person (item 10(2)). This step likely requires checking Medicare or department records and internal corporate records to identify past notices or determinations.
• If uncertain whether a person falls within the referenced categories, obtain guidance from the Department of Health or legal advice before submitting the application, because the instrument mandates disclosure where these conditions apply.

Step 8 , Prepare optional supporting information (Schedule 1, item 11)

• Include any additional information to support the application (item 11(1)). Use this field to address potential questions about shareholding arrangements, complex partnership allocations, or to contextualise disclosed fit-and-proper matters.

Step 9 , Verify data accuracy and document provenance

• Confirm all ABN/ACN numbers match official registers; for shareholder percentages and partnership shares, prepare to supply documentary evidence (eg, share registers, partnership agreements) on request. Although the instrument does not mandate documentary attachments, the department may request supporting documents.
• Keep records of searches and disclosures, especially concerning fit-and-proper enquiries, as those records will be relevant in any follow-up or review processes.

Step 10 , Submission and post-submission follow-up

• Submit the application in the form and by the channel specified by the Department of Health or the authorised administrative office for s 23DF applications; the instrument prescribes the particulars but not the lodgement process.
• Retain a complete copy of the submitted application and all supporting documentation. Be prepared to respond to departmental queries about any particulars, particularly concerning directors, shareholders and fit-and-proper disclosures.

Practical tips and risk management

• When in doubt about whether to disclose a past notice or determination, disclose and provide explanatory context using item 11. The instrument requires disclosure of such relationships and the consequences for non-disclosure are governed by the Health Insurance Act’s decision-making regime.
• If the corporate ownership structure is complex, prepare an ownership diagram and reconciliatory notes for principal shareholder percentages to satisfy the “approximate percentage of shareholding” requirement for companies (Schedule 1, item 7(1)(e)).
• Update trading name registration records to ensure the expiry date field in item 4(4) is current. If a trading name is not registered independently, be clear about ownership and the basis on which the trading name is used.
• Maintain a checklist mapped exactly to Schedule 1 items to ensure no required particulars are omitted. Because the instrument is a mandatory content prescription (s 5), administrative rejection or delays may arise from incomplete applications.

In summary, compliance with the instrument requires methodical collection and verification of corporate identifiers, governance data, authorised representative contacts, and thorough fit-and-proper screening tied to the specified provisions of the Health Insurance Act. The instrument prescribes what must be included; applicants should consult the Department of Health’s operational guidance about lodgement formats and any supporting evidentiary requirements.